APTO Aptose Earnings per share growth rate in current year

APTO (Aptose Biosciences) - company brandmark

Optimized raw material delivery for testing supports the trend shown on the annual EPS change scale. Robotic cell analysis accelerates research, yet the lack of profitability and biopharma volatility create financial risks. This chart illustrates capital volatility, and 74.00 captures the current indicator value, helping to assess the real business value of Aptose Biosciences Inc. (APTO).

APTO - Aptose Biosciences Earnings growth in current year over the range 07/04/2022 - 04/13/2025

Comprehensive metric breakdowns and analytics for aptose.com (APTO)

- stock value and consensus price forecast:
Market Price Aptose|APTO - Price Target Chart
- market capitalization data:
Market Value Aptose Biosciences|APTO - Enterprise Value
- balance sheet equity data:
Equity per Share Aptose Biosciences|APTO - Book Capitalization|Market Capitalization to Book Value Ratio aptose.com|APTO - Aggregate Company Assets
- debt burden and liquidity indicators:
Aggregate Debt to Equity Aptose Biosciences Inc.|APTO - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Aptose|APTO - Company Debts|Debts to Book Value Aptose Biosciences Inc.|APTO - Company Long-Term Debt|Short-Term Debt Volume Aptose Biosciences|Immediate Liquidity aptose.com
- earnings and market ratios statistics:
APTO - Net Income|Expected Net Income Aptose Biosciences Inc.|APTO - P/E Multiple|Future Price to Earnings Aptose Biosciences Inc|APTO - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Aptose Biosciences Inc.|APTO - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Aptose Biosciences|APTO - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months aptose.com|APTO - Earnings growth in current year|Expected earnings per share growth for next year Aptose Biosciences Inc.
- sales volume and revenue information:
APTO - Revenue and Sales Volume|Company Future Sales Aptose Biosciences Inc|APTO - P/S Multiple|Market Cap to Future Revenue Ratio Aptose Biosciences Inc.|APTO - Sales Growth YoY (Last Twelve Months)
Basic company analysis:APTO aptose.com
Product sample of Aptose Biosciences Inc.

To separate fundamental value from speculative noise, it is critical for investors to evaluate real capital efficiency. For Aptose Biosciences Inc. (APTO), which focuses on clinical trials for leukemia therapies, profit is secondary to expansion milestones. By analyzing the annual percentage trend of earnings per share, you can see the calculated change in EPS, reflecting the company's sensitivity to market shocks and borrowing costs.

Main competitors

Earnings per share growth rate in current year TG Pharma (TGTX)|Earnings per share growth in current year Arcellx Inc|Earnings per share growth rate in current year Disc Medicine, Inc. IRON|Earnings growth in current year SNDX|Kura Oncology Inc - Earnings per share growth this year|Earnings growth in current year ADCT (ADC Therapeutics S.A.)|FHTX (Foghorn Therapeutics) - Earnings per share trend in current year|VOR - Earnings per share growth in current year|NKTX - Earnings growth in current year|COEP: Earnings growth in current year|ATNM: Net earnings per one share growth for the current year|Earnings per share growth in current year Estrella Bio|CASI Pharmaceuticals, Inc. (CASI) - Expected net earnings per share growth this year|Earnings growth in current year MRKR|Earnings per share growth in current year INAB (IN8bio, Inc)|Earnings growth in current year ERNA (Eterna Therapeutics, Inc.)|GT Biopharma Inc (GTBP) - Earnings per share growth rate in current year|BPTH: Net earnings per share growth this year|MEIP - Earnings growth in current year|VINC (Vincerx) - Net earnings per share growth this year